Thomas Jefferson University clinical trial pipeline

4 trials changed in the last 30 days: 1 stopped, 2 with notable changes, 1 with a minor change only.

1. Stopped

   Nivolumab and BMS986205 · Stage II-IV Squamous Cell Cancer of…Nivolumab and BMS986205 · Stage II-IV Squamous Cell Cancer of the Head and Neck

   Trial terminated

   Also in this update: Results posted: Oct 19, 2026; Enrollment increased: 45 → 65 participants

   Thomas Jefferson University·Phase 2· NCT03854032· Registry history of NCT03854032 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

2. Notable

   Noninvasive Subharmonic Aided Pressure Estimation of Portal…Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

   Primary completion pushed from Feb 28, 2026 to Feb 28, 2028

   Also in this update: Study completion pushed from Apr 30, 2026 to Apr 30, 2028

   Thomas Jefferson University·Phase 3· NCT05470205· Registry history of NCT05470205 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

3. Notable

   PJI · Periprosthetic Joint Infection Bubble Study

   Primary completion pushed from Jun 1, 2028 to Jun 1, 2029

   Thomas Jefferson University·Phase 2· NCT07599865· Registry history of NCT07599865 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.